Genzyme has made money with external technology in children's drug market is generally considered too small to be attractive to other pharmaceutical companies. Now the competition is entering these markets, placing the business model Genzyme under new pressure. "Hide
by Henry W. Chesbrough, Clarissa Ceruti Source: Harvard Business School 20 pages. Publication Date: March 26, 2002. Prod. #: 602147-PDF-ENG
Related Case Solutions & Analyses:
Ducati
Howard Schultz and Starbucks Coffee Company
ICICI Banks Credit Card: Journey to Asian Leadership
Endesa Chile: Raising the Ralco Dam (A)
Slingshot Technology Inc. (B)
Life Sciences Revolution: Technical Primer
DeRemate.com: Building a Latin American Internet Auction Site
Auto Collection: Fords Better Idea for Selling Cars and Trucks
Driving towards a disruption?
Wolfgang Keller at Konigsbrau-TAK (A)
